Please login to the form below

Not currently logged in
Email:
Password:

Drug cure for breast cancer

Delegates at the European Breast Cancer Conference in Germany have seen new data revealing that Herceptin could prove an effective breast cancer cure
Delegates at the European Breast Cancer Conference (EBCC) in Germany have seen new data revealing that Herceptin could prove an effective breast cancer cure.

Herceptin (trastuzumab) has been developed for use in conjunction with chemotherapy prior to breast cancer surgery (neoadjuvant therapy). Results from the GeparQuatrro study, a randomised phase III trial, show that 45.5 per cent of female patients with HER2-positive breast cancer experienced complete tumour eradication.

Dr von Minckwitz of the University Women's Hospital in Frankfurt and managing director of German Breast Group, said: "Herceptin offers real hope for women with early breast cancer."

"Herceptin delivered on its promise of high tumour eradication when given to women with this aggressive form of breast cancer before their surgery," added Dr Minckwitz.

Over 1 million people are diagnosed with breast cancer worldwide with the disease claiming the lives of 400,000 patients annually.

According to Dr Untch, Helios Clinics in Berlin, "Herceptin makes women with this aggressive type of breast cancer feel more confident about their future".

HER2-positive breast cancer occurs in 20 to 30 per cent of all diagnosed cases. It is fast growing and is high likelihood of recurrence in patients. Herceptin is designed to target and block the function of HER2, a protein that has cancer causing potential.

18th April 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

The Holy Grail of HCP Access
This is the data you need to gain access....
No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....

Infographics